Codiak BioSciences, Inc. filed a motion in the US Bankruptcy Court seeking the dismissal of its Chapter 11 bankruptcy case on June 6, 2023. The reason being that the debtors liquidated substantially all their assets and the sale proceeds are not sufficient to repay the prepetition secured obligations in full. So, the debtor feels that dismissal of this case is in the best interests of the Debtors and its creditors.